子痫前期中补体受体CR3与CR4的功能障碍:遗传与功能研究
该病例对照研究基于FINNPEC和FINRISK队列,分析补体受体CR3与CR4基因变异与子痫前期的关联及其功能。发现CR3变异M441K与子痫前期显著相关(P=4.27E-4,OR=1.401,95%CI=1.167-1.682),CR4变异A251T增强与iC3b结合而W48R减弱结合。提示补体介导的吞噬功能改变可能与子痫前期相关。
要点
- CR3变异M441K与子痫前期风险增加相关(OR=1.401)。
- CR4变异A251T增强iC3b结合,W48R减弱结合。
- 补体受体功能改变可能参与子痫前期发病。
核心结论
- 补体受体CR3和CR4的遗传变异具有功能后果,并与子痫前期相关。
研究设计与样本
- 病例对照研究,FINNPEC队列纳入500例子痫前期孕妇和190例对照,FINRISK队列纳入122例子痫前期孕妇和1905例对照。
- 采用靶向外显子测序发现变异,并在COS-1细胞表面瞬时表达突变CR3或CR4,分析主要配体iC3b的结合。
主要发现
- CR3变异M441K与子痫前期关联最显著(P=4.27E-4,OR=1.401,95%CI=1.167-1.682),对iC3b黏附呈增加趋势(P=0.051)。
- CR4变异A251T增强CR4对iC3b的黏附,而W48R导致CR4与iC3b结合减少。
局限性
- 需要进一步研究以确定异常CR3和CR4活性是否导致携带相关变异个体的促炎和抗炎细胞因子反应改变,以及这些受体在子痫前期发病机制中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study genetic variants and their function within genes coding for complement receptors in pre-eclampsia. DESIGN: A case-control study. SETTING: Pre-eclampsia is a common vascular disease of pregnancy. The clearance of placenta-derived material is one of the functions of the complement system in pregnancy. POPULATION: We genotyped 500 women with pre-eclamptic pregnancies and 190 pregnant women without pre-eclampsia, as controls, from the FINNPEC cohort, and 122 women with pre-eclamptic pregnancies and 1905 controls from the national FINRISK cohort. METHODS: The functional consequences of genotypes discovered by targeted exomic sequencing were explored by analysing the binding of the main ligand iC3b to mutated CR3 or CR4, which were transiently expressed on the surface of COS-1 cells. MAIN OUTCOME MEASURES: Allele frequencies were compared between pre-eclamptic pregnancies and controls in genetic studies. The functional consequences of selected variants were measured by binding assays. RESULTS: The most significantly pre-eclampsia-linked CR3 variant M441K (P = 4.27E-4, OR = 1.401, 95% CI = 1.167-1.682) displayed a trend of increased adhesion to iC3b (P = 0.051). The CR4 variant A251T was found to enhance the adhesion of CR4 to iC3b, whereas W48R resulted in a decrease of the binding of CR4 to iC3b. CONCLUSIONS: Results suggest that changes in complement-facilitated phagocytosis are associated with pre-eclampsia. Further studies are needed to ascertain whether aberrant CR3 and CR4 activity leads to altered pro- and anti-inflammatory cytokine responses in individuals carrying the associated variants, and the role of these receptors in pre-eclampsia pathogenesis. TWEETABLE ABSTRACT: Genetic variants of complement receptors CR3 and CR4 have functional consequences that are associated with pre-eclampsia.
引用
- Lokki AI, Teirilä L, Triebwasser M, et al. Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study. BJOG. 2021. PMID: 33539617. doi:10.1111/1471-0528.16660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。